UPDATE: Needham & Company Upgrades CONMED (CNMD) to Buy
Tweet Send to a Friend
(Updated - October 6, 2021 6:26 AM EDT)
Needham & Company analyst Mike Matson upgraded CONMED (NASDAQ: CNMD) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham & Company analyst Mike Matson upgraded CONMED (NASDAQ: CNMD) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
